Oncology Biosimilar Market
                     Student Information 
SystemMarket
Oncology 
Biosimilar Market
Outlook, Growth Factors, Industry 
Share,  Size By 2026
Sample View Report
https://straitsresearch.co +1 6464807505, +44 203 sales@straitsresearc
m/ 318 2846 h.com
Oncology Biosimilar 
Market
Oncology Biosimilar Market Outlook, Growth Factors, Industry  
Share, Size by 2026| Straits Research
Oncology biosimilars are biologic agents that are highly similar to the originator biologic 
medicine, which is already approved by the U.S. FDA without clinically meaningful differences in 
terms of efficacy, safety, and purity with reference agents. Increasing prevalence of cancer due to 
unhealthy lifestyle and rising number of U.S. FDA approvals of biosimilars are the factors boosting 
the oncology biosimilars market.
Rising interest in biosimilars due to patent expiry of expensive biologic therapies is another key 
market drivers. Although, biosimilars are the cost effective alternative to the expensive cancer 
biologics, they offer significant challenge in the regulatory process. Thus, rigorously gauged 
approval process for manufacturing biosimilars is expected to limit the market growth.
https://straitsresearch.co +1 6464807505, +44 sales@straitsresearc
m/ 203 318 h.com
Oncology Biosimilar 
Market
The global oncology biosimilar market accounted for over USD 2655 million in 2017 and is 
expected to grow at a CAGR of 23 % during the forecast period, 2019–2026.
Click Here to Access the Sample Report:
https://straitsresearch.com/report/oncology-biosimilar-market/request-sample
https://straitsresearch.co +1 6464807505, +44 sales@straitsresearc
m/ 203 318 h.com
Oncology Biosimilar 
Market
Oncology Biosimilar Market Players Covered in This Report:
• oncology biosimilar market
• Teva Pharmaceutical Industries Ltd., 
• Biocon,
• STADA Arzneimittel AG, 
• Sandoz International GmbH, 
• Intas Pharmaceuticals Ltd., 
• Celltrion Inc., 
• Pfizer Inc., 
• Apotex Inc., 
• Dr. Reddy’s Laboratories Ltd.
A Summary of the Impact of COVID-19 on this Market:
The appearance of  COVID-19 has transported the globe to a halt. We understand that this 
health  disaster has brought an unprecedented impact on businesses across industries. 
However, this too  shall pass. Growing support from governments and various companies 
can benefit in the fight  against this highly transmissible disease. There are some 
businesses that are struggling and some  are thriving. General, almost every sector is 
anticipated to be stuck by the pandemic.         
                                                   Get This Full Report from Here:
          h   t t  p  s  : / / s  t  r a   i t s  rhettsepas:r/c/hs.tcroaitsresearch+1.c o6m46/4re8p0o7r5t0/5o,n +co4l4o gy-biosimilar-msaalrekse@t straitsresearc
m/ 203 318 h.com
Oncology Biosimilar 
Market
The Oncology Biosimilar Market has been segmented as below:
Types of Cancer By Region
• North America
• Breast Cancer • Europe
• Colorectal Cancer • Asia-Pacific
• Blood Cancer • LAMEA
• Neutropenia Cancer
• Non-Small Cell Lung Cancer
Drug Type
• mAb
• immunomodulators
• hematopoietic agents
• G-CSF
• Others
https://straitsresearch.co +1 6464807505, +44 sales@straitsresearc
m/ 203 318 h.com
Student Information 
SystemMarket
About Straits Research
StraitsResearch.com is a leading market research and market 
intelligence  organization, specializing in research, analytics, and 
advisory services along with  providing business insights & market 
research reports.
https://straitsresearch.com/
825 3rd Avenue, New York, NY, 
USA,
+1 6464807505, +44 203 318 
2846
[email protected]
https://straitsresearch.co +1 6464807505, +44 sales@straitsresearc
m/ 203 318 h.com